Humacyte, Inc.·4

May 25, 11:46 AM ET

Scheessele William John 4

4 · Humacyte, Inc. · Filed May 25, 2022

Insider Transaction Report

Form 4
Period: 2022-05-24
Scheessele William John
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2022-05-24$4.72/sh+10,525$49,67810,525 total

Documents

1 file
  • 4
    wf-form4_165349360232953.xmlPrimary

    FORM 4